An investigation for investors in scPharmaceuticals Inc. (NASDAQ: SCPH) shares over potential securities laws violations by scPharmaceuticals Inc. was announced.
San Diego, CA -- (SBWIRE) -- 10/31/2018 -- An investigation was announced conerning potential securities laws violations by scPharmaceuticals Inc. and certain of its directors and officers in connection with certain financial statements.
Investors who purchased shares of scPharmaceuticals Inc. (NASDAQ: SCPH), have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by scPharmaceuticals Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Burlington, MA based scPharmaceuticals Inc., a clinical-stage pharmaceutical company, engages in the development and commercialization of various pharmaceutical products.
scPharmaceuticals Inc. went public in November 2017 and sold 6,400,000 shares of common stock at a public offering price of $14.00 per share, for gross proceeds of $89.6 million. Since then shares of scPharmaceuticals Inc. (NASDAQ: SCPH) declined to as low as $3.76 per share on October 29, 2018.
Those who purchased shares of scPharmaceuticals Inc. (NASDAQ: SCPH) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels